Targeted oncogene activation by site-specific recombination in transgenic mice.
AUTOR(ES)
Lakso, M
RESUMO
An efficient and accurate method for controlled in vivo transgene modulation by site-directed recombination is described. Seven transgenic mouse founder lines were produced carrying the murine lens-specific alpha A-crystallin promoter and the simian virus 40 large tumor-antigen gene sequence, separated by a 1.3-kilobase-pair Stop sequence that contains elements preventing expression of the large tumor-antigen gene and Cre recombinase recognition sites. Progeny from two of these lines were mated with transgenic mice expressing the Cre recombinase under control of either the murine alpha A-crystallin promoter or the human cytomegalovirus promoter. All double-transgenic offspring developed lens tumors. Subsequent analysis confirmed that tumor formation resulted from large tumor-antigen activation via site-specific, Cre-mediated deletion of Stop sequences.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=49474Documentos Relacionados
- Tissue- and site-specific DNA recombination in transgenic mice.
- Ligand-activated site-specific recombination in mice.
- Cre-mediated somatic site-specific recombination in mice.
- Flp recombinase promotes site-specific DNA recombination in embryonic stem cells and transgenic mice.
- Assembly and activation of site-specific recombination complexes
